MEBO versus topical Diltiazem versus a combination of both ointments in the treatment of acute anal fissure: a randomized clinical trial protocol

El Charif, Mohamad Hadi; Doughan, Samer; Kredly, Rawya; Kassas, Sara; Azab, Rayan; Sbaity, Eman
Department of Surgery, American University of Beirut Medical Center, Riad El-Solh, Beirut, Lebanon; Office of Medical Affairs, Gulf Pharmaceutical Industries – Julphar, United Arab Emirates, Beirut-Lebanon Offices, Beirut, Lebanon; Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon; Gulf Pharmaceutical Industries – Julphar, United Arab Emirates, Beirut-Lebanon Offices, Beirut, Lebanon
2021
2662-7671
Cover
摘要

Anal fissure is a common complication of the anorectal region and one of the most reported causes of anal pain. Acute anal fissure can be cured by surgery or medical treatment. There is an increase in the use of topical therapy for the treatment of anal fissures. A common topical drug used is Diltiazem (DTZ), a calcium-channel blocker, which relaxes the anal sphincter and thus promotes healing of the anal fissure. Moist exposed burn ointment (MEBO) is an ointment that is effective for the treatment of burns and wound healing and is becoming popular in the treatment of anal fissures.

关键词
Content Preview
再生医学汇
AI Research Assistant

您好,我是再生医学汇AI助手

您的专业再生医学研究助理,准备好探索生命科学了